Rao S, Samalin-Scalzi E, Evesque L, Ben Abdelghani M, et al. Retifanlimab with carboplatin and paclitaxel for locally recurrent or metastatic squamous cell carcinoma of the anal canal (POD1UM-303/InterAACT-2): a global, phase 3 randomised controlled trial. Lancet 2025;405:2144-2152.
PMID: 40517007